GDF15 and hepatocellular carcinoma: In other models of cancer that respond poorly to immunotherapy, such as hepatocellular carcinoma (HCC), GDF15 is also an ideal target because it plays a central role in the generation and activation of Tregs, thereby mediating an immunosuppressive response (141).